- Home
- OB vs CMPS Comparison
OB vs CMPS Comparison
Compare OB & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OB
- CMPS
- Stock Information
- Founded
- OB 2006
- CMPS 2020
- Country
- OB United States
- CMPS United Kingdom
- Employees
- OB N/A
- CMPS N/A
- Industry
- OB Industrial Machinery/Components
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- OB Industrials
- CMPS Health Care
- Exchange
- OB Nasdaq
- CMPS Nasdaq
- Market Cap
- OB 294.0M
- CMPS 246.5M
- IPO Year
- OB 2021
- CMPS 2020
- Fundamental
- Price
- OB $3.30
- CMPS $3.13
- Analyst Decision
- OB Buy
- CMPS Strong Buy
- Analyst Count
- OB 6
- CMPS 6
- Target Price
- OB $6.80
- CMPS $20.20
- AVG Volume (30 Days)
- OB 407.3K
- CMPS 913.7K
- Earning Date
- OB 05-08-2025
- CMPS 05-07-2025
- Dividend Yield
- OB N/A
- CMPS N/A
- EPS Growth
- OB N/A
- CMPS N/A
- EPS
- OB N/A
- CMPS N/A
- Revenue
- OB $889,875,000.00
- CMPS N/A
- Revenue This Year
- OB $68.11
- CMPS N/A
- Revenue Next Year
- OB $6.22
- CMPS N/A
- P/E Ratio
- OB N/A
- CMPS N/A
- Revenue Growth
- OB N/A
- CMPS N/A
- 52 Week Low
- OB $3.00
- CMPS $2.49
- 52 Week High
- OB $7.87
- CMPS $9.63
- Technical
- Relative Strength Index (RSI)
- OB 35.75
- CMPS 51.00
- Support Level
- OB $3.10
- CMPS $2.94
- Resistance Level
- OB $3.42
- CMPS $3.11
- Average True Range (ATR)
- OB 0.29
- CMPS 0.21
- MACD
- OB 0.04
- CMPS 0.07
- Stochastic Oscillator
- OB 24.41
- CMPS 98.46
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.